Vital Signsby BridgeheadAll voices

01  Voice · Sector leader · Rare diseases

Michael Epstein: no photograph is held, so the sector leader plate is shown instead.
Sector leader

Michael Epstein

Vice president, commercial strategy and pricing, Clinigen

Press citations per month · linked articles
1
0
Oct 2026Nov 2026to date
1

press citation on 1 topic since 13 Oct 2026 · last quoted 13 Oct 2026

02  Quoted on · 1 of 29 topics

Open the topic

Michael Epstein: key facts

Kind of voice
Sector leader
Role
Vice president, commercial strategy and pricing, Clinigen
Quoted on
Rare diseases
Tracked press citations
1
Most recently quoted
13 Oct 2026

04  The signal · where Michael Epstein sits on rare diseases

Ranked 31= of 100 voices quoted in the press on rare diseases, level with 69 others on 1 citation.

Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.

  1. 1Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)5
  2. 2=David Weitz portraitDavid WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
  3. 2=Tuomas Knowles portraitTuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
  4. 31=Lucy MartinClinicianPhysical therapist (aquatic therapist)1
  5. 31=Laura JohnsonClinicianLead Clinical Trials Midwife, University Hospitals of Derby and Burton1
  6. 31=Michael EpsteinSector leaderVice president, commercial strategy and pricing, Clinigen1
  7. 31=Susanne MichelSector leaderVice president, head of HTA methods and evidence planning, Clinigen1
  8. 31=Carmen BozicAcademicM.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer at Vertex1

Showing the leaders and the ranks around 31=, of 100 voices · See every voice on the topic →

05  On the record · press

What Michael Epstein has said

By outlet · linked articles
  • bioxconomy.com1

Where Michael Epstein has been quoted

  1. 01MFN Pricing and the Future of Rare Disease Launchesbioxconomy.com · 13 Oct 2026

Verbatim

“All of our clients are nervous about MFN. All of them are asking us about it.”
Vice president, commercial strategy and pricing, Clinigen · Rare diseases · bioxconomy.com · 13 Oct 2026 · Read the article

Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.